Desjardins R E, Canfield C J, Haynes J D, Chulay J D
Antimicrob Agents Chemother. 1979 Dec;16(6):710-8. doi: 10.1128/AAC.16.6.710.
A rapid, semiautomated microdilution method was developed for measuring the activity of potential antimalarial drugs against cultured intraerythrocytic asexual forms of the human malaria parasite Plasmodium falciparum. Microtitration plates were used to prepare serial dilutions of the compounds to be tested. Parasites, obtained from continuous stock cultures, were subcultured in these plates for 42 h. Inhibition of uptake of a radiolabeled nucleic acid precursor by the parasites served as the indicator of antimalarial activity. Results of repeated measurements of activity with chloroquine, quinine, and the investigational new drug mefloquine demonstrated that the method is sensitive and precise. Several additional antimalarial drugs and compounds of interest were tested in vitro, and the results were consistent with available in vivo data. The use of P. falciparum isolates with known susceptibility to antimalarial drugs also permitted evaluation of the cross-resistance potential of each compound tested. The applications and expectations of this new test system within a drug development program are discussed.
开发了一种快速、半自动微量稀释法,用于测定潜在抗疟药物对培养的人疟原虫恶性疟原虫红细胞内无性体的活性。使用微量滴定板制备待测试化合物的系列稀释液。从连续传代培养物中获得的疟原虫在这些平板中传代培养42小时。疟原虫对放射性标记核酸前体摄取的抑制作用作为抗疟活性的指标。用氯喹、奎宁和研究新药甲氟喹重复测量活性的结果表明该方法灵敏且精确。体外测试了几种其他抗疟药物和感兴趣的化合物,结果与现有的体内数据一致。使用对抗疟药物具有已知敏感性的恶性疟原虫分离株还可以评估所测试的每种化合物的交叉耐药潜力。讨论了这种新测试系统在药物开发计划中的应用和期望。